glp-1 shortage fda takes aim at telehealth companies for promoting unofficial weight loss drug dupes FDA says shortage of GLP-1

Semaglutide (Ozempic, Wegovy) starts at .25mg/week and then goes up from there

Abstract Introduction Overweight and obesity are major global health issues, increasing disease risk and straining healthcare systems

Neurodegeneration Alzheimers disease and dementia A review of 15 randomized controlled trials including over 2,400 subjects found that higher doses of Cerebrolysin were associated with reduced psychological symptoms and potentially slower progression in patients with Alzheimers disease and dementia

Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N

10.3389/frdem.2024.1456716 188 LyleA